Epidemiology of Klebsiella Pneumoniae in China

Klebsiella Pneumoniae Infection Clinical Trial

Official title: Klebsiella Pneumoniae Infection in China: Epidemiology, Molecular Characteristics, Treatment, and Outcome

Status Recruiting

Clinical Trial Summary

Klebsiella pneumoniae is one of the most common pathogens causing both community-onset and nosocomial infection. More worse, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics,outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.

Clinical Trial Description

All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as baseline data, outcomes etc, were recorded. Finially, to find the prevalence, risk factors, characteristics, outcome and the rationality of the current therapy for the Klebsiella pneumoniae infection in China. ;

Related Conditions & MeSH terms

• Infection
• Klebsiella Infections
• Klebsiella Pneumoniae Infection
• Pneumonia

• NCT number: NCT03598543
• Study type: Observational
• Source: Sir Run Run Shaw Hospital
• Contact: Ying-zhi FANG, Master
• Phone: +86 57186006811
• Email: fyz4817@126.com
• Status: Recruiting
• Start date: June 1, 2018
• Completion date: December 31, 2018